Long intergenic non-protein coding RNA 2054 (LINC02054)

Long intergenic non-protein coding RNA 2054 (LINC02054) is classified as a long intergenic non-coding RNA (lincRNA), which are RNA transcripts longer than 200 nucleotides that do not overlap annotated protein-coding genes and generally do not encode proteins[1][3][9]. LincRNAs as a class are known for regulatory roles such as chromatin remodeling, transcriptional regulation, and modulation of the activity of microRNAs or proteins, with diverse cellular and disease functions, particularly in cancer[3][5][9]. Unlike other lincRNAs (for example LINC02154), there is currently no published evidence describing a specific biological function, disease association, or therapeutic relevance for LINC02054 itself[1][3]. There is also no evidence that it is targeted by or interacts with any known drugs, nor does it serve as a biomarker or therapeutic target based on current available data. The entry is a valid non-protein-coding RNA gene annotation, but without further functional characterization, it cannot be considered a therapeutic target or disease-relevant molecule at this time. This entry is marked as is_incorrect: true because LINC02054, specifically, does not have enough characterized information to fulfill common requirements for structured drug discovery/therapeutics databases; it should not be confused with nearby or similarly named lincRNAs such as LINC02154, the latter of which has been studied as an oncogenic player in cancer and could be a potential target[2][4].

Other names

LINC02054